[ad_1]
December 10, 2023 at 10:58 pm EST
BENGALURU (Reuters) – Shares of Indian drug-maker Dr. Reddy’s Laboratories have been down 6.5% on Monday after the U.S. Food and Drug Administration issued three observations for the corporate’s plant in Telangana state.
(Reporting by Varun Vyas in Bengaluru; Editing by Dhanya Ann Thoppil)
© Reuters – 2023
[adinserter block=”4″]
[ad_2]
Source link